By Allison Proffitt
June 3, 2014 | Pathway Genomics has launched its BRCATrue test for BRCA 1 and BRCA 2 and its BRCA One for One program, hoping to offer the industry’s best BRCA genetic test and make it accessible to a wide range of women.
The company believes the One for One program to be rare in health care. "We thought a lot about it and we talked to a lot of global patient advocacy organizations and we thought... for every test that was ordered, we can donate a test to someone in need," Ardy Arianpour, Chief Strategy Officer for Pathway Genomics told Bio-IT World.
Pathway is partnering with eight advocacy groups representing an international patient population: Susan G. Koman for the Cure, Bright Pink, Living Beyond Breast Cancer, National Ovarian Cancer Coalition, Young Survival Coalition, Foundation for Women's Cancer, Facing Our Risk of Cancer, and Sharsheret.
Read the full story at Clinical Informatics News.